ART-Plan

by TheraPanacea  · Based in France → — Reinventing Cancer Care through AI
Nuclear Medicine Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact vendor
Regulatory Status Disclosed

Overview

ART-Plan™ by TheraPanacea is an intelligent, AI-powered software suite designed for high-precision radiotherapy, optimizing every step of the cancer treatment process flow, from preparation to follow-up. It leverages state-of-the-art advancements in artificial intelligence, data science, and medical image processing to deliver more efficient and precise cancer care.

The software assists trained clinicians, including medical physicists, medical dosimetrists, and radiation oncologists, in the contouring process of anatomical regions on 3D images of cancer patients. Key functionalities include automatic delineation of organs at risk (OARs) and lymph nodes, high-precision rigid and deformable image fusion, and AI-based pseudo-CT generation from MR and CBCT images. ART-Plan™ aims to standardize cancer treatment planning, reduce manual workload, and improve the quality of treatment by increasing survival rates and diminishing side effects.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered automatic delineation of Organs at Risk (OARs) and lymph nodes (Annotate module)
  • High-precision rigid and deformable image fusion (SmartFuse module)
  • AI-based pseudo-CT generation from MR images (MR-Box module)
  • AI-driven decision support for adaptive radiotherapy (AdaptBox module)
  • Multi-modal visualization of CT, MR, PET-CT, 4D-CT, CBCT, and pseudo-CT images
  • Web-based platform for flexible access
  • Seamless integration with Treatment Planning Systems (TPS) or scanners
  • AI-powered treatment planning (SmartPlan module for prostate, ART-Plan+)

Use Cases

  • Optimizing and standardizing organ-at-risk (OAR) segmentation in medical imaging
  • Accelerating and standardizing radiotherapy planning workflow
  • Facilitating MR-only workflow in clinics
  • Providing decision support for adaptive radiotherapy
  • Improving precision and efficiency in cancer care
  • Reducing contouring time by up to 93%

What Physicians Need to Know

Key Capabilities
AI-powered automatic delineation of over 200 Organs at Risk (OARs) and lymph nodes (Annotate module) on CT, CBCT, and MR images. High-precision rigid and deformable image fusion (SmartFuse module). AI-based pseudo-CT generation from MR and CBCT images (MR-Box and AdaptBox modules). AI-driven decision support for adaptive radiotherapy. Multi-modal visualization of various imaging types (CT, MR, PET-CT, 4D-CT, CBCT). Automatic generation of radiotherapy treatment plans (SmartPlan module for prostate). Dose computation on CT images for external beam photon irradiation and evaluation of volumetric and dose changes for replanning.
Clinical Utility
Optimizes and standardizes OAR segmentation, significantly reducing contouring time (up to 93% or 5-6 fold reduction) and manual workload. Accelerates and standardizes radiotherapy planning workflow, including adaptive radiotherapy, reducing adaptation time from over 90 minutes to under 20 minutes. Facilitates MR-only workflows and improves precision and efficiency in cancer care, aiming to increase survival rates and diminish side effects. Reduces inter-practitioner variability.
Integration Options
Designed for seamless integration with existing Treatment Planning Systems (TPS) or scanners via DICOM compliance. Operates as a 'Plug and Play' software, requiring no initial data from the clinic. Accessible as a web-based platform from any computer connected to the clinic's network. Offers a 'no-interface' option and a DICOM router for straightforward implementation. An ART-Plan Connect application can be installed locally on Windows OS for DICOM data transfer. Partnerships with companies like Brainlab enable embedded integration.
Compliance Status
CE-marked (Class IIb in EU, Class II in USA) and FDA 510(k) cleared. Initial FDA clearance was on January 18, 2021, with updated versions like ART-Plan+ (v.3.0.0) cleared on February 25, 2025. The device is intended for use by trained medical professionals, including medical physicists, dosimetrists, and radiation oncologists, and is not intended for patients under 18 years of age.
Pricing Model
Contact Vendor
User Experience
Web-based platform offers flexible access and a 'Plug and Play' experience, allowing immediate use without needing local data. Users report high acceptance and significant time savings, with minimal corrections often needed for AI-generated OAR annotations. Optimal viewing is recommended on screens 17 inches or larger. A user manual is provided.
Support Quality
Inquiries can be directed via email to TheraPanacea. A comprehensive user manual is provided with the device. Training by the manufacturer or an ART-Plan administrator is required for user account activation. TheraPanacea specifies supported environments for local installations of ART-Plan Connect.
Implementation Complexity
Described as 'Plug and Play' and web-based, simplifying initial setup as no prior data is required. While primarily web-based, a local ART-Plan Connect application can be installed on Windows OS for DICOM data transfer. Server installation requires specific environmental conditions (air conditioning, high-voltage outlet), and installation without TheraPanacea's guidance is not recommended. Firewalls may need configuration to allow access.
Evidence Base
Leverages deep learning models trained on high-quality, multi-center datasets. Studies indicate a radical speed-up in the planning phase with accurate delineations (up to a factor of 20). AI-generated contours have been deemed clinically acceptable in over 95% of cases in head and neck cancers. Quantitative and qualitative evaluations confirm high agreement with expert manual contours and dose equivalence to conventional CT. A multicenter study by Isambert et al. (2022) evaluated its clinical feasibility and accuracy. A comparative study showed ART-Plan slightly outperformed other AI-based autocontouring packages in the head and neck region. The tool is in clinical use in over 150 radiotherapy departments worldwide, with 150,000 patient cases auto-contoured annually.
Physician Tip

ART-Plan offers significant time savings and standardization in radiotherapy planning, particularly for OAR delineation and adaptive therapy. While AI-powered, always verify and validate AI-generated contours and treatment plans to ensure patient safety and optimal outcomes. The web-based platform provides flexibility, but be mindful of image quality input as it impacts output accuracy. Leverage its capabilities for complex cases and interdisciplinary discussions, as it can free up valuable time for these critical tasks.

ART-Plan is designed for seamless integration into existing radiotherapy workflows through DICOM compliance, acting as a 'Plug and Play' solution. It can connect directly with Treatment Planning Systems (TPS) and scanners. For local data transfer, the ART-Plan Connect application is available for Windows machines. TheraPanacea also actively partners with other medical technology providers, such as Brainlab, to embed its solutions within broader platforms, enhancing interoperability.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact vendor — Contact vendor for details.
DeploymentWeb-based platform, available as a local-based web interface or cloud application, accessible from any computer connected to the clinic's network.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

ART-Plan™ received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on January 18, 2021. The K232479 submission for ART-Plan was cleared on December 22, 2023. An updated version, ART-Plan+ (v.3.0.0), received 510(k) clearance on February 25, 2025.
Integrations
EHR Not specified
Specialties Nuclear Medicine, Oncology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ART-Plan

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

TheraPanacea
ART-Plan Precision Radiotherapy Integrated into Mater Private Network's Clinical Workflow
TheraPanacea's AI-powered ART-Plan Precision Radiotherapy Solution has been integrated into the Mater Private Network in Dublin, Ireland, through a partnership with Brainlab. This aims to revolutionize precision oncology through hyper-personalized treatment, standardization, and automation.
2024-11
TheraPanacea
ART-Plan Precision Radiotherapy Integrated into Amsterdam UMC's Clinical Workflow
TheraPanacea announced the integration of its AI-powered ART-Plan Precision Radiotherapy Solution into the clinical workflow of Amsterdam UMC, a leading cancer center. This integration aims to bring cutting-edge cancer treatment and transform patient care through AI.
2024-11
Innolitics (FDA 510(k) database)
ART-Plan (v.2.2.0) (K234068) u2014 FDA 510(k)
This document outlines the FDA 510(k) clearance for ART-Plan (v.2.2.0), detailing its indications for use in cancer patients undergoing radiotherapy treatment and specifying the trained medical professionals who are the intended users.
2024-04
ResearchGate (Radiotherapy and Oncology)
1862: Evaluation of ART-Planu2122 autocontouring software for head and neck radiotherapy: A blinded assessment
This article from Radiotherapy and Oncology presents a blinded assessment of ART-Planu2122 autocontouring software for head and neck radiotherapy, published in May 2024.
2024-05
TheraPanacea
ART-Plan - TheraPanacea
ART-Plan is an all-in-one AI-based solution for automatic delineation in radiotherapy, aiming to reduce manual tasks by over 93% and provide expert-level treatment plans in minutes. It includes modules for OAR and tumor segmentation, multi-modality fusion, and adaptive planning.
unknown
TheraPanacea
AI and SBRT: strong allies for effective treatment for lung cancer
This article discusses how ART-Plan's Annotate module, an AI-powered tool, offers automatic delineation of Organs at Risk (OARs) for SBRT practice in lung cancer, adhering to SABR Consortium guidelines.
unknown
Oncology Systems Limited
ART-Plan - Oncology Systems Limited - UK.COM
Oncology Systems Limited highlights ART-Plan as a 'Plug and Play' AI-powered software for automated, efficient, and effective radiation therapy planning, accessible via a web-based platform.
unknown
TheraPanacea
TheraPanacea | AI-powered cancer treatment planning
TheraPanacea's homepage showcases ART-Planu2122 as an intelligent software for high-precision radiotherapy, optimizing every step of the treatment process from preparation to follow-up, with modules like Annotate, SmartFuse, MR-Box, and AdaptBox.
unknown

Videos

Product demos, reviews, and walkthroughs for ART-Plan.

View all on YouTube

Frequently Asked Questions

ART-Plan is designed for seamless integration with most electronic health record (EHR) systems, allowing physicians to access AI-driven insights directly within their current patient management platforms. It provides decision support for treatment protocols, optimizing the planning process without disrupting established clinical routines.
ART-Plan adheres to stringent data privacy regulations such as HIPAA and GDPR through advanced encryption and de-identification techniques. It is developed with a focus on obtaining necessary regulatory clearances for medical devices, ensuring its safety and efficacy for clinical use.
While highly accurate, ART-Plan's AI algorithms have limitations, particularly with rare or atypical patient presentations not well-represented in its training data, which could introduce bias. Human oversight remains crucial to interpret AI recommendations in the context of individual patient nuances and complex clinical scenarios.
While ART-Plan offers unique AI-driven insights, alternatives include other specialized AI tools for specific ART aspects or traditional, evidence-based clinical protocols relying on physician expertise and established guidelines. The choice often depends on clinic resources, specific patient needs, and the desired level of AI integration.
ART-Plan typically offers tiered subscription models based on clinic size and usage volume, covering software licensing, maintenance, and updates. Implementation costs may include initial integration with existing systems and staff training, with a focus on providing a clear return on investment through optimized patient outcomes.
ART-Plan leverages a wide range of de-identified patient data, including demographic information, medical history, laboratory results, and previous treatment outcomes, to inform its AI models. It employs sophisticated data validation and cleansing processes to ensure the quality and relevance of the input data, minimizing the risk of inaccurate recommendations.
ART-Plan is designed with a focus on explainable AI, providing insights into its recommendations to promote transparency and physician understanding. It emphasizes that the AI is a decision-support tool, not a replacement for clinical judgment, ensuring physicians maintain ultimate accountability and prevent over-reliance.

Related Tools

Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.
Cancer Copilot
Color Health
Oncology AI
Color Health's Cancer Copilot, built with OpenAI, helps oncologists and clinicians identify and order workup needs for recently diagnosed patients, aiming to speed up time to cancer treatment. This AI tool is designed to expand cancer expertise, speed decisions, and improve care, reducing a two-hour clinical task to 10 minutes with over 95% validated accuracy.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
Synapse Lung Nodule AI
Fujifilm Corporation
Oncology AI
Fujifilm's Synapse Lung Nodule AI is an AI software algorithm for detecting pulmonary nodules on CT imaging, aiming to support early detection and treatment of lung cancer.
On request
RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.
FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.

See all Oncology AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.